Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1305578 | 0.77 | TSHR (0.33) | TSHRNFKB1CYP2C19 | |
| SCHEMBL4747481 | 0.74 | TSHR (0.32) | TSHRNFKB1CYP2C19 | |
| SCHEMBL19543128 | 0.74 | TSHR (0.33) | TSHRNFKB1CYP2C19 | |
| SCHEMBL29742365 | 0.72 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL15698088 | 0.72 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL3661697 | 0.72 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL28594770 | 0.72 | TSHR (0.31) | TSHRNFKB1CYP2C19 | |
| SCHEMBL3159770 | 0.72 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL22787369 | 0.72 | — | — | |
| SCHEMBL1232478 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018103-B2 | Flow cell and methods | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-06-25 | — | — | US | disclosed |
| US-12018103-B2 | Flow cell and methods | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-06-25 | — | — | US | disclosed |
| US-20230295455-A1 | FLOW CELLS | ILLUMINA, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230295455-A1 | FLOW CELLS | ILLUMINA, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20220372182-A1 | FLOW CELL AND METHODS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-11-24 | — | — | US | disclosed |
| US-20220185927-A1 | HYDROGEL | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-06-16 | — | — | US | disclosed |
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | Oji Holdings Corporation (JP) | 2021-09-14 | — | — | US | disclosed |
| US-11066571-B2 | Pattern forming method, under coating agent, and laminate | Oji Holdings Corporation (JP) | 2021-07-20 | — | — | US | disclosed |
| US-20210147603-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | Oji Holdings Corporation (JP) | 2021-05-20 | — | — | US | disclosed |
| US-10982032-B2 | Self-assembly composition for pattern formation and pattern forming method | Oji Holdings Corporation (JP) | 2021-04-20 | — | — | US | disclosed |
| US-10872937-B2 | Organic electroluminescence display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-22 | — | — | US | disclosed |
| US-20200048491-A1 | PATTERN FORMING METHOD, UNDER COATING AGENT, AND LAMINATE | Oji Holdings Corporation (JP) | 2020-02-13 | — | — | US | disclosed |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | Oji Holdings Corporation (JP) | 2019-07-11 | — | — | US | disclosed |
| US-20190043936-A1 | ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | IAPP, SAMM50, MAN1B1 | TSHR 4339/4885NFKB1 3145/4885CYP2C19 3767/4885 |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | IAPP, SAMM50, MAN1B1 | TSHR 4339/4885NFKB1 3145/4885CYP2C19 3767/4885 |
| US-11066571-B2 | Pattern forming method, under coating agent, and laminate | LMNB2, MCM4, LMNB1 | TSHR 4777/4885NFKB1 2934/4885CYP2C19 2937/4885 |
| US-20200048491-A1 | PATTERN FORMING METHOD, UNDER COATING AGENT, AND LAMINATE | LMNB2, MCM4, LMNB1 | TSHR 4777/4885NFKB1 2934/4885CYP2C19 2937/4885 |
| US-20210147603-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | IAPP, SAMM50, MAN1B1 | TSHR 4339/4885NFKB1 3145/4885CYP2C19 3767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.